Total Funding
48
54
Total FundingPost-IPO Equity raised
Growth Score
-33 pts
Heat Score
-17 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
59656
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.
George Jones: Chief Commercial OfficerPast Role: Currax Pharmaceuticals, Vice President Global Marketing & Commercial Operations
About the Company
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics. The company's licensed products focus on the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a bacterial skin infection.
Biofrontera was founded in 2015 and is headquartered in Woburn,
Massachusetts, United States.
